Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rocket Doctor AIAIRDF +7.59%27 Return-on-Tangible-Asset is -780.60% as of Mar. 2026. GuruFocus rates AIRDF with a GF Score™ of 27/100. The stock has 7 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Rocket Doctor AI ranks worse than 98.53% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Rocket Doctor AI's annualizedNet Income for the quarter that ended in Mar. 2026 was $-13.52 Mil. Rocket Doctor AI's average total tangible assets for the quarter that ended in Mar. 2026 was $1.73 Mil. Therefore, Rocket Doctor AI's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was -780.60%.
The historical rank and industry rank for Rocket Doctor AI's Return-on-Tangible-Asset or its related term are showing as below:
AIRDF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -2207.64 Med: -793.52 Max: -583.3
Current: -822.51
During the past 7 years, Rocket Doctor AI's highest Return-on-Tangible-Asset was -583.30%. The lowest was -2207.64%. And the median was -793.52%.
AIRDF's Return-on-Tangible-Asset is ranked worse than 98.53% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 2.5
vs AIRDF: -822.51
Rocket Doctor AI (OTCPK:AIRDF) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Rocket Doctor AI Return-on-Tangible-Asset Related Terms
Rocket Doctor AI Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Rocket Doctor AI's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AIRDF vs VEEV, BTSG, TEM: Return-on-Tangible-Asset Comparison
For the Health Information Services subindustry, Rocket Doctor AI's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rocket Doctor AI Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rocket Doctor AI's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Rocket Doctor AI's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of -780.60% mean?
Rocket Doctor AI (AIRDF) has a Return-on-Tangible-Asset of -780.60% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Rocket Doctor AI and its competitors. According to the industry distribution chart, Rocket Doctor AI ranks #671 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 98.5%.
Is Rocket Doctor AI's Return-on-Tangible-Asset too high?
Rocket Doctor AI's current Return-on-Tangible-Asset is -780.60%. Based on the distribution chart, Rocket Doctor AI ranks #671 out of 681 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Rocket Doctor AI has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Rocket Doctor AI's Return-on-Tangible-Asset compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Rocket Doctor AI ranks #671 out of 681 companies for Return-on-Tangible-Asset. This places Rocket Doctor AI in the lower half of its industry. The industry median Return-on-Tangible-Asset is 2.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.50, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Rocket Doctor AI and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rocket Doctor AI's current Return-on-Tangible-Asset is -780.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rocket Doctor AI stock overvalued right now?
Rocket Doctor AI (AIRDF) has a current Return-on-Tangible-Asset of -780.60%. The current Return-on-Tangible-Asset is -780.60%. Rocket Doctor AI's overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Rocket Doctor AI (AIRDF), the current Return-on-Tangible-Asset is -780.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Rocket Doctor AI Inc delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company's proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians world-wide. Alongside the GLM and its AI-powered digital health platform and marketplace. The group empowers over 300 MDs to provide care to more than 700,000 patients. Its proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.
27GF Score
Get the complete analysis for AIRDF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIRDF has been successfully added to your 
